CLINICAL_TRIALS
trial_result
· 2017-12-06
Clinical Trial Update: Study to Compare the Safety and Anti-HIV Effect of GSK1265744 Versus Placebo in HIV-1 Infected Adults (ITZ112929) [Phase 2]
Summary
Phase 2 trial comparing cabotegravir (GSK1265744) to placebo in HIV-1 infected adults to assess safety and antiviral effect. The study results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: ViiV Healthcare | Conditions: Infection, Human Immunodeficiency Virus | Phase 2 | Status: COMPLETED | Results posted: 2017-12-06